Alcohol Use Disorder Clinical Trial
— HOMEOfficial title:
Enhancing Prospective Thinking in Early Recovery
Verified date | March 2024 |
Source | Indiana University |
Contact | Sarah Turo, BA |
Phone | 317-963-7220 |
sturo[@]iu.edu | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing alcohol use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering alcohol use disorder (AUD) persons. The main question[s] this trial aims to answer are: Will the Virtual Reality (VR) intervention decrease the number of stimulant use days? Will the VR intervention produce longer abstinence periods during follow-up visits? Will the VR intervention increase alcohol abstinence rates? Will the VR intervention increase future self-identification? Will the VR intervention increase self-reported future time perspective? Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day? Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups? Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.
Status | Recruiting |
Enrollment | 500 |
Est. completion date | July 31, 2027 |
Est. primary completion date | July 31, 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: - Abstinence between =14 days and =1 year - Verbal endorsement of commitment to recovery - Outpatient - Psychotropic drugs for SUD-comorbidity - Drug/alcohol abstinence = 24 hours at the time of the study day visit - English comprehension Exclusion Criteria: - Unstable medical disorders - Habitual drug use - Mu-opioid drugs - Smell/taste disorders - Unstable psychiatric conditions - Extravagant/elaborate face tattoos |
Country | Name | City | State |
---|---|---|---|
United States | Indiana University School of Medicine - Goodman Hal | Indianapolis | Indiana |
Lead Sponsor | Collaborator |
---|---|
Indiana University | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reduced Use of Drug Using Days | The Virtual Reality Avatar experience will reduce drug using days. | Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit | |
Primary | Increased Length of Abstinence | The Virtual Reality Avatar experience will increase the length of abstinence periods. | Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. | |
Primary | Increased (overall) Abstinence | The Virtual Reality Avatar experience will increase abstinence. | Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. | |
Primary | Future Self-identification with Future Self Continuity Questionnaire | The Virtual Reality Avatar experience will increase future self-identification. | Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit | |
Primary | Future Time Perspective with the Delayed Discounting Behavioral Task and Future Self Continuity Questionnaire | The Virtual Reality Avatar experience will increase future time perspective. | Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. | |
Primary | Delayed Reward Preference with the Delayed Discounting Behavioral Task | The Virtual Reality Avatar experience will increase preference for delayed rewards. | Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04788004 -
Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse
|
||
Recruiting |
NCT05684094 -
Mechanisms of Risky Alcohol Use in Young Adults: Linking Sleep to Reward- and Stress-Related Brain Function
|
N/A | |
Completed |
NCT03406039 -
Testing the Efficacy of an Online Integrated Treatment for Comorbid Alcohol Misuse and Emotional Problems
|
N/A | |
Completed |
NCT03573167 -
Mobile Phone-Based Motivational Interviewing in Kenya
|
N/A | |
Completed |
NCT04817410 -
ED Initiated Oral Naltrexone for AUD
|
Phase 1 | |
Active, not recruiting |
NCT04267692 -
Harm Reduction Talking Circles for American Indians and Alaska Natives With Alcohol Use Disorders
|
N/A | |
Completed |
NCT03872128 -
The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders
|
Phase 1 | |
Completed |
NCT02989662 -
INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers
|
Phase 1/Phase 2 | |
Recruiting |
NCT06030154 -
Amplification of Positivity for Alcohol Use
|
N/A | |
Active, not recruiting |
NCT05419128 -
Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19
|
N/A | |
Completed |
NCT04564807 -
Testing an Online Insomnia Intervention
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT04203966 -
Mental Health and Well-being of People Who Seek Help From Their Member of Parliament
|
||
Recruiting |
NCT05861843 -
Craving Assessment in Patients With Alcohol Use Disorder Using Virtual Reality Exposure
|
||
Terminated |
NCT04404712 -
FAAH Availability in Psychiatric Disorders: A PET Study
|
Early Phase 1 | |
Enrolling by invitation |
NCT04128761 -
Decreasing the Temporal Window in Individuals With Alcohol Use Disorder
|
N/A | |
Not yet recruiting |
NCT06444243 -
Psilocybin-assisted Therapy for Alcohol Use Disorder
|
Phase 2 | |
Not yet recruiting |
NCT06337721 -
Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults
|
N/A | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Enrolling by invitation |
NCT02544581 -
Preliminary Analysis of the Soberlink Alcohol Breath Analyzer System's (SABA) Clinical Utility During Aftercare
|
N/A |